Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
aminocaproic acid
aminocaproic acid
| Form | Strength |
|---|---|
| SOLUTION, INTRAVENOUS | 250 mg/mL |
| SYRUP, ORAL | 1.25 g/5 mL |
| TABLET, ORAL | 500 mg |
Last updated: Nov. 30, 2021
aminocaproic acid
| Form | Strength |
|---|---|
| SOLUTION, INTRAVENOUS | 250 mg/mL |
| SYRUP, ORAL | 1.25 g/5 mL |
| TABLET, ORAL | 500 mg |
Aminocaproic acid for thrombolytic reversal: See Reversal Guideline 900.5010
Anticoagluation Management while on ECMO, see protocol 922.5063
Massive Transfusion Protocol, see protocol 915.6150 and Pharmacologic Adjuncts for Massive Transfusion
Aminocaproic acid mouthwash is NON-formulary. Formulary agent of choice for bleeding risk management in anticoagulated patients undergoing minor dental procedures is 5% tranexamic acid mouthwash.